Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1/Cisplatin vs 5-FU/Cisplatin in Advanced Gastric Cancer (FLAGS)
NCT00400179Phase 3Completed
- Sponsor
- Taiho Oncology
- Start
- May 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of tegafur in gastric cancer (GC) and gastroesophageal junction adenocarcinoma (2 arms), sponsored by Taiho Oncology. Primary endpoint: Median Survival. Started May 2005; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00400179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00400179.